# A client with CKD and type 2 diabetes takes finerenone. Which action should the nurse take first?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=522072&lang=en  
> language: en  
> subject: Adverse Effects/Contraindications/Interactions  
> category: PPT

## Question

A client with CKD and type 2 diabetes takes finerenone. Which action should the nurse take first?

History

Vitals

Labs

Orders

Notes

CKD with type 2 diabetes and persistent albuminuria

(데이터 없음)

Potassium 5.8 mEq/L; eGFR 32 mL/min/1.73 m2

(데이터 없음)

(데이터 없음)

1

Administer finerenone and repeat potassium in 6 months.

✕

2

Hold the dose and contact the prescriber about potassium 5.8 mEq/L and the new clarithromycin prescription.

✕

3

Encourage a potassium supplement before the dose.

✕

4

Double finerenone because albuminuria persists.

✕

## Explanation

Hyperkalemia and a strong CYP3A4 inhibitor create immediate finerenone safety concerns, so the dose and interaction require clarification before administration.

## In-depth explanation

Quick answer
Stop for high potassium plus a strong interaction.

Why this is correct
Finerenone can cause hyperkalemia and is contraindicated with strong CYP3A4 inhibitors; potassium and renal function guide interruption and restart.

Easy analogy or mental picture
Think of medication safety as a control panel: identify the dangerous signal, change the correct control, and verify the response.

Memory hook
Cue, action, response, reassessment.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving the continuing indication.

Why the other choices are wrong
Options that delay escalation, ignore a contraindication, or change therapy without authorization do not close the safety loop.References
1DailyMed: KERENDIA (finerenone)Potassium and eGFR assessment, hyperkalemia monitoring, dose interruption, and interaction safety

## Clinical scenario

Medication safety review
Verify the indication, current assessment, laboratory trend, timing, interactions, authorized action, and measurable follow-up.

## Related questions

- [A client is admitted to the emergency department after ingesting an unknown amount of acet…](https://mymerci.kr/pages/nclex_q.php?qn_id=362720&lang=en)
- [A client with chronic heart failure is prescribed metoprolol 25 mg orally twice daily. Bef…](https://mymerci.kr/pages/nclex_q.php?qn_id=362756&lang=en)
- [A 28-year-old client with type 1 diabetes receives regular insulin 6 units and NPH insulin…](https://mymerci.kr/pages/nclex_q.php?qn_id=362792&lang=en)
- [A client receives IV vancomycin 1 g every 12 hours for MRSA bacteremia. Before the next do…](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=en)
- [A client with bipolar disorder has been taking lithium carbonate 600 mg orally three times…](https://mymerci.kr/pages/nclex_q.php?qn_id=362894&lang=en)
- [A nurse is monitoring a client receiving a continuous IV heparin infusion for pulmonary em…](https://mymerci.kr/pages/nclex_q.php?qn_id=363988&lang=en)
- [A nurse is preparing to initiate a weight-based continuous IV unfractionated heparin infus…](https://mymerci.kr/pages/nclex_q.php?qn_id=364107&lang=en)
- [A nurse is providing discharge teaching to a 65-year-old client newly prescribed warfarin …](https://mymerci.kr/pages/nclex_q.php?qn_id=364872&lang=en)

## Read in another language

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=522072&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=522072&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=522072&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=522072&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=522072&lang=vi)

---

More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en)

_For study reference only. Always follow current clinical guidelines and your institution’s protocols._